SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Bergstrand Ulf)
 

Search: WFRF:(Bergstrand Ulf) > A semi-mechanistic ...

A semi-mechanistic model for characterization of regional absorption properties and prospective prediction of plasma concentrations following administration of new modified release formulations

Bergstrand, Martin, 1977- (author)
Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Pharmacometrics Research Group
Söderlind, Erik (author)
Eriksson, Ulf G (author)
show more...
Weitschies, Werner (author)
Karlsson, Mats O (author)
Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Pharmacometrics Research Group
show less...
 (creator_code:org_t)
English.
  • Journal article (other academic/artistic)
Abstract Subject headings
Close  
  • Methods to study in vivo gastro intestinal (GI) transit and/or regional absorption of pharmaceuticals are available and increasingly used in drug development. A modelling approach to utilize the information generated in such studies for prospective predictions of absorption from newly developed modified release formulations was outlined and tested for the investigational drug AZD0837. This work was a natural extension to the companion article “A semi-mechanistic model to link in vitro and in vivo drug release for modified release formulations”. The drug release model governed the amount of substance released in distinct GI regions over time. GI distribution of released drug substance, region specific rate and extent of absorption and the influence of concomitant food intake were estimated with the model. The model was informed by data from a magnetic marker monitoring study and an intubation study with local administration in colon. Disposition estimates were further supported by observations following administration of oral solution and intravenous infusion of AZD0837. Distinctly different absorption properties were characterized for different GI regions. Bioavailability over the gut-wall was estimated to be high for substance released in the stomach and absorbed in duodenum (70%) compared to substance released and absorbed in the small intestine (25%). Bioavailability was once again higher in colon (70%) but on the other hand considerably slower than in the earlier parts of the GI tract. The established model was largely successful in predicting plasma concentration following administration of three newly developed formulations for which no clinical data had been applied during model building.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)

Keyword

Modified release
IVIVC
Magnetic marker monitoring
Mechanistic modeling
NONMEM
Other pharmacy
Övrig farmaci
Pharmacokinetics and Drug Therapy
Farmakokinetik och läkemedelsterapi

Publication and Content Type

vet (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view